Risks and benefits of LHRH agonists as antifertility agents

This publication has 11 references indexed in Scilit:

• SUSTAINED GONADAL SUPPRESSION IN FERTILE WOMEN WITH THE LHRH AGONIST BUSERELIN
  Clinical Endocrinology, 1983
• Fortschritte in der kontrazeptiven Anwendung des LH-RH-Agonisten Buserelin: diskontinuierliche Medikation mit gestageninduzierter Abbruchblutung
  Geburtshilfe und Frauenheilkunde, 1982
• Influence of the LH-RH analogue buserelin on cyclic ovarian function and on endometrium. A new approach to fertility control?
  Contraception, 1981
• Decreased Pituitary Responsiveness and Inhibition of the Luteinizing Hormone Surge and Ovulation in the Stumptailed Monkey (Macaca arctoides) by Chronic Treatment with an Agonist of Luteinizing Hormone-Releasing Hormone
  Endocrinology, 1980
• INTRANASAL GONADOTROPIN-RELEASING HORMONE AGONIST AS A CONTRACEPTIVE AGENT
  The Lancet, 1979
• Inhibition of ovulation in women by intranasal treatment with a luteinizing hormone-releasing hormone agonist
  Contraception, 1979
• Inhibition of ovulation in women by chronic treatment with a stimulatory lrh analogue — A new approach to birth control?
  Contraception, 1978
• THE EFFECT OF D-Ser (TBU)⁶-LH-RH-EA¹⁰UPON GONADOTROPIN RELEASE IN NORMALLY CYCLIC WOMEN
  Journal of Clinical Endocrinology & Metabolism, 1977
• Estrogen use and cancer risk
  Published by American Medical Association (AMA) ,1977
• Precursors of Corpus Carcinoma Estrogens and Adenomatous Hyperplasia
  American Journal of Obstetrics and Gynecology, 1947